Patient Education Sheet Library
Search Results
Pembrolizumab and GVD
The combination of pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) is used for Hodgkin…
Treatment Given by InfusionDownloads:
Download (English)Ibrutinib and Rituximab
The combination of ibrutinib and rituximab is used for chronic lymphocytic leukemia (CLL), small lymphocytic…
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Acalabrutinib and BR
The combination of acalabrutinib, bendamustine, and rituximab is used for mantle cell lymphoma (MCL).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Lenalidomide and Rituximab
The combination of lenalidomide and rituximab (R2) is used for follicular lymphoma or marginal zone…
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Daratumumab and CyBorD
The comination of daratumumab, cyclophosphamide, bortezomib, and dexamethasone (Dara-CyBorD) is used for multiple myeloma and…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Cetuximab plus Radiation
Cetuximab plus radiation therapy is used for head and neck cancer.
Treatment Given by InfusionDownloads:
Cetuximab
Cetuximab is used for colon and rectal (colorectal) cancer, head and neck cancer, penile cancer,…
Treatment Given by InfusionDownloads:
Decitabine and Venetoclax
The combination of decitabine and venetoclax is used for acute myeloid leukemia (AML).
Treatment Given by Infusion Treatment Taken by MouthDownloads:
High-Dose Methotrexate
High-dose methotrexate is used for certain types of leukemia, lymphoma, brain tumors, and bone cancer.
Treatment Given by InfusionDownloads:
Cladribine
Cladribine is used for hairy cell leukemia.
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
